Literature DB >> 8949931

Possible involvement of calmodulin-dependent kinases in Ca(2+)-dependent enhancement of [3H]5-hydroxytryptamine uptake in rat cortex.

A Yura1, Y Kiuchi, T Uchikawa, J Uchida, K Yamazaki, K Oguchi.   

Abstract

Effects of Ca2+ on [3H]5-hydroxytryptamine (5-HT) uptake into rat cortical synaptosomes were studied. The uptake was enhanced in the presence of Ca2+ in Krebs-Ringer medium and the uptake at 0.3-5 mM Ca2+ was 2.4-2.7 times greater than that observed in the absence of Ca2+. The maximal increase at the concentration of 1 mM Ca2+ was achieved after 2 min preincubation. Ca(2+)-dependent enhancement of the [3H]5-HT uptake reflected an increase in Vmax of the uptake process. However, Kd and Bmax values for [3H]paroxetine were not significantly changed in the presence of 1 mM Ca2+ compared with Ca(2+)-free condition. On the other hand, uptake was still enhanced after synaptosomes were washed with Ca(2+)-free after preincubation with 1 mM Ca2+. Staurosporine (a protein kinase C inhibitor) and wortmannin (a myosin light chain kinase inhibitor) did not affect Ca(2+)-dependent enhancement of the uptake, whereas 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazin e (KN-62, an inhibitor of Ca2+ /calmodulin-dependent kinase II) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7, a calmodulin antagonist) significantly reduced it. Moreover, L-type, but not P- or N-type, voltage-dependent Ca(2+)-channel blockers suppressed enhancement of the uptake. These results indicate that Ca(2+)-dependent enhancement of [3H]5-HT uptake is mediated by activation of calmodulin-dependent protein kinases, suggesting a possibility of calmodulin-dependent regulation of in vivo 5-HT uptake.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949931     DOI: 10.1016/0006-8993(96)00762-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Synaptosomal lactate dehydrogenase isoenzyme composition is shifted toward aerobic forms in primate brain evolution.

Authors:  Tetyana Duka; Sarah M Anderson; Zachary Collins; Mary Ann Raghanti; John J Ely; Patrick R Hof; Derek E Wildman; Morris Goodman; Lawrence I Grossman; Chet C Sherwood
Journal:  Brain Behav Evol       Date:  2014-03-28       Impact factor: 1.808

2.  Ca2+ dependent surface trafficking of norepinephrine transporters depends on threonine 30 and Ca2+ calmodulin kinases.

Authors:  Uhna Sung; Francesca Binda; Valentina Savchenko; William A Owens; Lynette C Daws
Journal:  J Chem Neuroanat       Date:  2016-12-23       Impact factor: 3.052

3.  Enhanced brain stem 5HT₂A receptor function under neonatal hypoxic insult: role of glucose, oxygen, and epinephrine resuscitation.

Authors:  T R Anju; P K Korah; S Jayanarayanan; C S Paulose
Journal:  Mol Cell Biochem       Date:  2011-04-12       Impact factor: 3.396

4.  Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A.

Authors:  Uhna Sung; Randy D Blakely
Journal:  Mol Cell Neurosci       Date:  2006-12-26       Impact factor: 4.314

5.  Histamine Receptors Regulate the Activity, Surface Expression, and Phosphorylation of Serotonin Transporters.

Authors:  Balasubramaniam Annamalai; Durairaj Ragu Varman; Rebecca E Horton; Lynette C Daws; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  ACS Chem Neurosci       Date:  2020-01-22       Impact factor: 4.418

Review 6.  Regulation of monoamine transporters: Role of transporter phosphorylation.

Authors:  Sammanda Ramamoorthy; Toni S Shippenberg; Lankupalle D Jayanthi
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

7.  131I-MIBG targeting of neuroblastoma cells is acutely enhanced by KCl stimulation through the calcium/calmodulin-dependent kinase pathway.

Authors:  Hyun Woo Chung; Jin Won Park; Eun Jeong Lee; Kyung-Ho Jung; Jin-Young Paik; Kyung-Han Lee
Journal:  Cancer Biother Radiopharm       Date:  2013-06-13       Impact factor: 3.099

8.  Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.